http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9724357-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4be65d64fe39b8d5ea93345d0d4fbe26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ba21c4123db789685f1f3388ca1ea7c5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f66a5c8ebc9f789ac4d6fdf7dfc1f2a9
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-00
filingDate 1996-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e50423228334bd95c4c261c8fbf549a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2773eebd186451148e9e087ec51f241d
publicationDate 1997-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-9724357-A1
titleOfInvention Process for synthesis and purification of a compound useful in the preparation of acyclovir
abstract Intermediate chemical compounds useful in the preparation of acyclovir and a method of synthesizing and purifying the intermediate chemical compounds. Diacetyl-guanine is alkylated and the resulting product washed with an alcohol to produce a relatively pure, crystalline diacetyl-acyclovir (DA-ACV). The diacetyl-acyclovir (DA-ACV) is hydrolyzed in the presence of potassium hydroxide to a novel potassium salt of acyclovir, acyclovir potassium enolate. The acyclovir potassium salt is converted into essentially pure acyclovir. The step of hydrolyzing diacetyl-acyclovir and forming the potassium salt occurs simultaneously. The potassium salt of acyclovir is converted to acyclovir by dissolving in water in the presence of an acid to generate an essentially pure acyclovir. The resulting acyclovir normally needs no further purification and meets the specification of U.S.P. XXIII. Thus, the invention is directed to the synthesis of intermediate purified diacetyl-acyclovir, the conversion of the diacetyl-acyclovir to an acyclovir-potassium salt, and the conversion of the acyclovir-potassium salt to acyclovir.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112300166-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113620955-A
priorityDate 1995-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0704445-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0564006-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0665229-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4146715-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1567671-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0289992-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128585769
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393245
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136385364
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID228546862
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4282999
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129742532
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226423192
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136482458
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136360183
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226690445
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID231982337
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129662902
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID228546866
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129149603
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136020804
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21196919
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID134401309
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129187076
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128126843
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22253347
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3014716
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123132306
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID231427
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID228546869
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398513
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31347
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129046299
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID589711
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5333
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129680196
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5359277
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5324412
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393693
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23225568
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID519314
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6101
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234288712
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226512630
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135761770
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136093953
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226690443
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128835551
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395421
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129914155
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135506856
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID228667766
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID100999
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226690444
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID88369453
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID228667764
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128610196

Total number of triples: 74.